High Sequence Variability of the ppE18 Gene of Clinical Mycobacterium tuberculosis Complex Strains Potentially Impacts Effectivity of Vaccine Candidate M72/AS01E
- PMID: 27011018
- PMCID: PMC4806982
- DOI: 10.1371/journal.pone.0152200
High Sequence Variability of the ppE18 Gene of Clinical Mycobacterium tuberculosis Complex Strains Potentially Impacts Effectivity of Vaccine Candidate M72/AS01E
Abstract
The development of an effective vaccine is urgently needed to fight tuberculosis (TB) which is still the leading cause of death from a single infectious agent worldwide. One of the promising vaccine candidates M72/AS01E consists of two proteins subunits PepA and PPE18 coded by Rv0125 and Rv1196. However, preliminary data indicate a high level of sequence variability among clinical Mycobacterium tuberculosis complex (MTBC) strains that might have an impact on the vaccine efficacy. To further investigate this finding, we determined ppE18 sequence variability in a well-characterized reference collection of 71 MTBC strains from 23 phylogenetic lineages representing the global MTBC diversity. In total, 100 sequence variations consisting of 96 single nucleotide polymorphisms (SNPs), three insertions and one deletion were detected resulting in 141 variable positions distributed over the entire gene. The majority of SNPs detected were non-synonymous (n = 68 vs. n = 28 synonymous). Strains from animal adapted lineages, e.g., M. bovis, showed a significant higher diversity than the human pathogens such as M. tuberculosis Haarlem. SNP patterns specific for different lineages as well as for deeper branches in the phylogeny could be identified. The results of our study demonstrate a high variability of the ppE18 gene even in the N-terminal domains that is normally highly conserved in ppe genes. As the N-terminal region interacts with TLR2 receptor inducing a protective anti-inflammatory immune response, genetic heterogeneity has a potential impact on the vaccine efficiency, however, this has to be investigated in future studies.
Conflict of interest statement
Figures


Similar articles
-
PPE18 and PepA Variations in Mycobacterium tuberculosis Clinical Isolates from Makassar, Indonesia: Challenges for Immune Recognition and Vaccine Development.Int J Mycobacteriol. 2025 Apr 1;14(2):191-200. doi: 10.4103/ijmy.ijmy_70_25. Epub 2025 Jun 20. Int J Mycobacteriol. 2025. PMID: 40540664
-
DNA polymorphisms in the pepA and PPE18 genes among clinical strains of Mycobacterium tuberculosis: implications for vaccine efficacy.Infect Immun. 2007 Dec;75(12):5798-805. doi: 10.1128/IAI.00335-07. Epub 2007 Sep 24. Infect Immun. 2007. PMID: 17893137 Free PMC article.
-
Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.Front Cell Infect Microbiol. 2017 May 31;7:226. doi: 10.3389/fcimb.2017.00226. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28620588 Free PMC article.
-
The Systematic Review and Meta-Analysis on the Immunogenicity and Safety of the Tuberculosis Subunit Vaccines M72/AS01E and MVA85A.Front Immunol. 2020 Oct 8;11:1806. doi: 10.3389/fimmu.2020.01806. eCollection 2020. Front Immunol. 2020. PMID: 33133057 Free PMC article.
-
Immunogenicity and Safety of the M72/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis.Front Immunol. 2019 Sep 3;10:2089. doi: 10.3389/fimmu.2019.02089. eCollection 2019. Front Immunol. 2019. PMID: 31552037 Free PMC article. Review.
Cited by
-
The PE/PPE family proteins of Mycobacterium tuberculosis: evolution, function, and prospects for tuberculosis control.Front Immunol. 2025 Jun 17;16:1606311. doi: 10.3389/fimmu.2025.1606311. eCollection 2025. Front Immunol. 2025. PMID: 40599786 Free PMC article. Review.
-
Enhancing TB Vaccine Efficacy: Current Progress on Vaccines, Adjuvants and Immunization Strategies.Vaccines (Basel). 2023 Dec 29;12(1):38. doi: 10.3390/vaccines12010038. Vaccines (Basel). 2023. PMID: 38250851 Free PMC article. Review.
-
Tuberculosis vaccine development: from classic to clinical candidates.Eur J Clin Microbiol Infect Dis. 2020 Aug;39(8):1405-1425. doi: 10.1007/s10096-020-03843-6. Epub 2020 Feb 15. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32060754 Free PMC article. Review.
-
Peptides-Based Vaccine MP3RT Induced Protective Immunity Against Mycobacterium Tuberculosis Infection in a Humanized Mouse Model.Front Immunol. 2021 Apr 26;12:666290. doi: 10.3389/fimmu.2021.666290. eCollection 2021. Front Immunol. 2021. PMID: 33981313 Free PMC article.
-
The Mycobacterium tuberculosis genome at 25 years: lessons and lingering questions.J Clin Invest. 2023 Oct 2;133(19):e173156. doi: 10.1172/JCI173156. J Clin Invest. 2023. PMID: 37781921 Free PMC article. Review.
References
-
- World Health Organisation. Global tuberculosis report 2014. 2014. Available: http://www.who.int/tb/publications/global_report/en/
-
- Frick M. The tuberculosis vaccine pipeline. Back to basic science. 2014. Available: http://www.treatmentactiongroup.org/sites/g/files/g450272/f/201407/2014%...
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous